Inhibition of C-C chemokine receptor-2 improves insulin resistance and hepatic steatosis in db/db mice

被引：0
|
作者：
Tamura, Yukinori
Sugimoto, Masayuki
Murayama, Toshinori
Kita, Toru
Yokode, Masayuki
Araikyoto, Hidenori
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A169 / A169
页数：1
相关论文
共 50 条
  • [1] C-C chemokine receptor-2 inhibitor ameliorates insulin resistance and hepatic steatosis in db/db mice.
    Tamura, Yukinori
    Arai, Hidenon
    Sugimoto, Masayuki
    Murayama, Toshinori
    Ueda, Yukihiko
    Kanamori, Hiroshi
    Ono, Koh
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    CIRCULATION, 2007, 116 (16) : 170 - 170
  • [2] α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2
    Kim, Hong Min
    Kim, You Mi
    Huh, Ji Hye
    Lee, Eun Soo
    Kwon, Mi Hye
    Lee, Bo Ra
    Ko, Hyun-Jeong
    Chung, Choon Hee
    PLOS ONE, 2017, 12 (06):
  • [3] C-C Chemokine Receptor 2 Inhibitor Improves Diet-Induced Development of Insulin Resistance and Hepatic Steatosis in Mice
    Tamura, Yukinori
    Sugimoto, Masayuki
    Murayama, Toshinori
    Minami, Manabu
    Nishikaze, Yuki
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2010, 17 (03) : 219 - 228
  • [4] Inhibition of CCR2 Ameliorates Insulin Resistance and Hepatic Steatosis in db/db Mice
    Tamura, Yukinori
    Sugimoto, Masayuki
    Murayama, Toshinori
    Ueda, Yukihiko
    Kanamori, Hiroshi
    Ono, Koh
    Ariyasu, Hiroyuki
    Akamizu, Takashi
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (12) : 2195 - 2201
  • [5] Honokiol Improves Insulin Resistance, Hepatic Steatosis, and Inflammation in Type 2 Diabetic db/db Mice
    Kim, Young-Je
    Jung, Un Ju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [6] C-c Chemokine Receptor 2 Inhibitor Ameliorates Diet-induced Insulin Resistance and Hepatic Steatosis in Mice
    Tamura, Yukinori
    Murayama, Toshinori
    Minami, Manabu
    Nishikaze, Yuki
    Kita, Toru
    Yokode, Masayuki
    Arai, Hidenori
    CIRCULATION, 2009, 120 (18) : S1051 - S1051
  • [7] Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice
    Omori, Kazuno
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Nomoto, Hiroshi
    Kameda, Hiraku
    Cho, Kyuyong
    Terauchi, Yasuo
    Atsumi, Tatsuya
    DIABETES, 2019, 68
  • [8] PHARCOLOGICAL BLOCKADE OF CCR2 INHIBITS THE DEVELOPMENT OF INSULIN RESISTANCE AND HEPATIC STEATOSIS IN DB/DB MICE
    Tamura, Y.
    Sugimoto, M.
    Murayama, T.
    Kita, T.
    Yokode, M.
    Arai, H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 12 - 13
  • [9] Electromagnetic Fields Ameliorate Insulin Resistance and Hepatic Steatosis by Modulating Redox Homeostasis and SREBP-1c Expression in db/db Mice
    Zhai, Mingming
    Yan, Xi
    Liu, Jiangzheng
    Long, Zi
    Zhao, Siyan
    Li, Wendan
    Liu, Ying
    Hai, Chunxu
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1035 - 1042
  • [10] Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy
    Yang, S. J.
    IglayReger, H. B.
    Kadouh, H. C.
    Bodary, P. F.
    DIABETOLOGIA, 2009, 52 (05) : 972 - 981
12345